Is there a role for lung surgery in initially unresectable non-small cell lung cancer after tyrosine kinase inhibitor treatment?

Is there a role for lung surgery in initially unresectable non-small cell lung cancer after tyrosine kinase inhibitor treatment?

Abstract Background The role of lung surgery in initially unresectable non-small cell lung cancer (NSCLC) after tyrosine kinase inhibitor (TKI) treatment remains unclear. We aimed to assess the survival benefits of patients who underwent surgery for regressed or regrown tumors after receiving TKI tr...

Full description

Bibliographic Details
Main Authors: Nguk Chai Diong, Chia-Chuan Liu, Chih-Shiun Shih, Mau-Ching Wu, Chun-Jen Huang, Chen-Fang Hung
Format: Article
Language:English
Published: BMC 2022-11-01
Series:World Journal of Surgical Oncology
Subjects:
Epidermal growth factor receptor (EGFR)
Molecular targeted therapy
Non-small cell lung cancer (NSCLC)
VATS
Online Access:https://doi.org/10.1186/s12957-022-02833-6

Internet

https://doi.org/10.1186/s12957-022-02833-6

Similar Items